Aug 3, 2022
In this episode, we take a look back at Dr. Roger McIntyre’s presentation on the treatment spectrum for depression and mania. In this sneak peek, Dr. McIntyre focuses on the current treatments that are available for the bipolar disorder spectrum. He addresses the implications of comorbid substance abuse with respect to pharmacological treatments. He also discusses lifestyle factors that can be preventative against cognitive decline associated with mood disorders.
Dr. Roger S. McIntyre is currently a Professor of Psychiatry and
Pharmacology at the University of Toronto and Head of the Mood
Disorders Psychopharmacology Unit at the University Health Network,
Toronto, Canada. Dr. McIntyre is also Executive Director of the
Brain and Cognition Discovery Foundation in Toronto, Canada.
Dr. McIntyre was named by Thomson Reuters in 2014 and 2015, as one
of “The World’s Most Influential Scientific Minds”. This
distinction is given by publishing the largest number of articles
that rank among those most frequently cited by researchers globally
in 21 broad fields of science and social science during the
previous decade.
Dr. McIntyre is involved in multiple research endeavors which
primarily aim to characterize the association between mood
disorders, notably cognitive function and medical comorbidity. His
works broadly aims to characterize the underlying causes of
cognitive impairment in individuals with mood disorders and their
impact on workplace functioning. This body of work has provided a
platform for identifying novel molecular targets to treat and
prevent mood disorders and accompanying cognitive impairment.
Dr. McIntyre is a contributor to the “Florida Medicaid Drug Therapy
Management Program for Behavioral Health: Guidelines for the
treatment of adults with Major Depressive Disorder and Bipolar
Disorder”. Dr. McIntyre is also the co-chair of the Canadian
Network for Mood and Anxiety Treatments (CANMAT) Task Force on the
Treatment of Comorbidity in Adults with Major Depressive Disorder
or Bipolar Disorder and as well a contributor to the “CANMAT
Guidelines for the Treatment of Depressive Disorders and Bipolar
Disorders”. Dr. McIntyre has published hundreds of peer-reviewed
articles and has edited and/or co-edited several textbooks on mood
disorders.